These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4809445)

  • 21. Humoral inhibitors of the immune response in uremia. I. Effect of serum and of the supernatant of spleen cultures from uremic rats on the mixed lymphocyte reaction.
    Raskova J; Morrison AB
    Lab Invest; 1978 Jan; 38(1):103-9. PubMed ID: 146111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum creatinine concentration at the onset of uremia: higher levels in black males.
    Abuelo JG; Shemin D; Chazan JA
    Clin Nephrol; 1992 Jun; 37(6):303-7. PubMed ID: 1638782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of several uremic parameters on uremic serum inhibition of lymphocyte blastogenesis.
    Modai D; Hadi Y; Weissgarten J; Peller S; Kaufman S
    Immunol Lett; 1985; 9(5):275-8. PubMed ID: 2987112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells.
    Chen NX; O'Neill KD; Duan D; Moe SM
    Kidney Int; 2002 Nov; 62(5):1724-31. PubMed ID: 12371973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PERITONEAL-EXTRACORPOREAL RECIRCULATION DIALYSIS A TECHNIQUE FOR IMPROVING EFFICIENCY OF PERITONEAL DIALYSIS.
    SHINABERGER JH; SHEAR L; BARRY KG
    Invest Urol; 1965 May; 2():555-66. PubMed ID: 14283599
    [No Abstract]   [Full Text] [Related]  

  • 27. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
    Wu-Wong JR; Nakane M; Chen YW
    Life Sci; 2013 Feb; 92(2):161-6. PubMed ID: 23261531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the uremic syndrome through hemodialysis.
    Funck-Brentano JL
    Biomater Med Devices Artif Organs; 1974; 2(4):321-43. PubMed ID: 4462862
    [No Abstract]   [Full Text] [Related]  

  • 32. Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients.
    Mansouri K; Halsted JA; Gombos EA
    Arch Intern Med; 1970 Jan; 125(1):88-93. PubMed ID: 5410656
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diamine oxidase activity in plasma and urine in uremia.
    Tam CF; Kopple JD; Wang M; Swendseid ME
    Nephron; 1979; 23(1):23-7. PubMed ID: 109782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
    Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis.
    Fontán MP; Rodríguez-Carmona A; Cordido F; García-Buela J
    Am J Kidney Dis; 1999 Nov; 34(5):824-31. PubMed ID: 10561137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the influence of peritoneal dialysis on cellular immunity by the E-rosette inhibition test.
    Giacchino F; Pozzato M; Piccoli G
    Artif Organs; 1984 May; 8(2):156-60. PubMed ID: 6732543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
    Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT;
    Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended hemodialysis in children with chronic renal failure.
    Fine RN; De Palma JR; Lieberman E; Donnell GN; Gordon A; Maxwell MH
    J Pediatr; 1968 Nov; 73(5):706-13. PubMed ID: 4300674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.